Company / SG&A per Share
Penumbra, Inc. SG&A per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$17.24
FY2025
5-year range
$7.49 / $17.24
FY2021-FY2025
Trend
+16.2%
vs FY2024
Sector context
#27 of 156
Health Care
What the data says
Penumbra, Inc.'s sg&a per share of $17.24 is higher than 83% of companies in the Health Care sector (FY2025). SG&A per Share has increased for 4 consecutive years, from $7.49 in FY2021 to $17.24 in FY2025.
Based on SEC 10-K filings.
17.24 in FY2025 with a 5-year CAGR of +16.0%. Top quartile in the Health Care sector.
Increased from $13.29 to $17.24 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +31.2%
- 5-Year CAGR
- +16.0%
- 10-Year CAGR
- -
Sector benchmark
Bottom 17% in Health CareTop 83% of 156This company $17.24 Sector average $11421.53
▼
-99.8% below sector average
Key checks
Key Insights
- Penumbra, Inc.'s sg&a per share has grown for 4 consecutive years.
- In FY2025, sg&a per share increased 16.2% year-over-year.
- Ranks #27 out of 156 companies in the Health Care sector.
- Lowest sg&a per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 3.11 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $17.24 | +16.2% |
| FY2024 | $14.84 | +11.7% |
| FY2023 | $13.29 | +74.0% |
| FY2022 | $7.64 | +2.0% |
| FY2021 | $7.49 | -8.7% |
| FY2020 | $8.20 | +53.2% |
| FY2019 | $5.35 | +21.6% |
| FY2018 | $4.40 | +34.5% |
| FY2017 | $3.27 | -34.0% |
| FY2016 | $4.96 | -76.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026